EULAR recommendations for the management of familial Mediterranean fever
Ozen S, Demirkaya E, Erer B, et al.
Ann Rheum Dis · 2016
Grade Aclinical guideline
Key Findings
- ●Colchicine as first-line lifelong treatment
- ●IL-1 blockers for colchicine-resistant cases
- ●Regular monitoring of SAA/CRP to assess subclinical inflammation
Referenced in (1 disease)
ID: pmid-26802180DOI: 10.1136/annrheumdis-2015-208690PMID: 26802180